Delivery Order SPE2DB20D3103-SPE2DB23FM6P6
- Not listed
- This federal contract award, valued at $3,471.77, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of modafinil 200mg tablets. The contract, which has a completion date of April 25, 2024, is a firm fixed-price delivery order with no set-aside requirements. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $2,139.34 for the supply of 30-count 100 mg Modafinil tablets. The contract is not a set-aside and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,922.41 firm fixed-price delivery order is for the supply of 4554407659 - Modafinil 200 mg tablets. This award is associated with Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The IDC enables...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,503.79 Firm Fixed Price Delivery Order is for the supply of 4,567,776,229 tablets of the drug Modafinil 100mg. The contract has an ultimate completion date of April 3, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (SPE2DB22D1106|SPE2DB25FEGH3) from the Defense Logistics Agency (DLA) with a ceiling value of $2,162.28. It is for the supply of Modafinil 100 mg tablets, a pharmaceutical product used for various medical conditions. The contract has an ultimate completion date of April 4, 2025 and was awarded on April 3, 2025 under a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award, with ID SPE2DB25D3005|SPE2DB25FQEUC, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,951.03 firm fixed-price delivery order is for the supply of 4,568,093,163 tablets of the medication Modafinil 100 mg. The contract has an ultimate completion date of May 1, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, with ID SPE2DB22D2007|SPE2DB25FJ0UR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,751.48 delivery order contract is for the supply of 4,567,956,496 units of the drug Modafinil 100 mg tablet, with a firm fixed price and an ultimate completion date of April 18, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp...
- This federal contract award, with ID SPE2DB22D1106 and SPE2DB24FEGA1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,715.67 firm fixed price delivery order is for the supply of 4564029439 - Modafinil 200 mg tablet 30s, with a performance period through March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to...
- This federal contract award, SPE2DB22D2005|SPE2DB24FJGT4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,299.40, is for the delivery of 4563414136 - Modafinil 200 mg Tablets, 90s, and has an ultimate completion date of January 24, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant Indefinite Delivery...
- This federal contract award, valued at $2,054.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,962,528 units of the medication Modafinil 100 mg tablet in 30-count packages. The contract has an ultimate completion date of April 21, 2025 and a firm fixed price pricing type. This award is not associated with a set-aside designation,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FM6P6Delivery Order
This federal contract award, with an ID of SPE2DB20D3103|SPE2DB23FM6P6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $7,477.55, is for the delivery of 4560151626 - Modafinil 200 mg tablets in quantities of 90s. The contract is a Firm Fixed Price Delivery Order and has a completion date of March 7, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued at $999,999,999, and the Department of Justice Federal Bureau of Investigation, valued at $750,000, which enable efficient government procurement of essential pharmaceutical and medical supplies. This contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 3/6/23 |